Oxidopamine

Oxidopamine

SCHEMBL718426

Cl.NCCc1cc(O)c(O)cc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Oxidopamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A known ✓ P08913 2/20 0.50
DRD2 known ✓ P14416 2/20 0.50
DRD1 known ✓ P21728 2/20 0.50
DRD4 known ✓ P21917 2/20 0.50
SLC6A2 known ✓ P23975 2/20 0.50
DRD3 known ✓ P35462 2/20 0.50
SLC6A3 known ✓ Q01959 2/20 0.50
GAA known ✓ P10253 1/20 0.50
ADRB2 known ✓ P07550 1/20 0.46
HTR1A known ✓ P08908 1/20 0.46
PTGS1 known ✓ P23219 1/20 0.46
ADRA1D known ✓ P25100 1/20 0.46
ADRA1A known ✓ P35348 1/20 0.46
ADRA1B known ✓ P35368 1/20 0.46
RECQL P46063 5/20 1.00
TDP1 Q9NUW8 5/20 1.00
KDM4E B2RXH2 4/20 1.00
MAPT P10636 4/20 1.00
RAD52 P43351 3/20 1.00
MAPK1 P28482 3/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxidopamine SCHEMBL30862335 1.00 RECQL (1.00) RECQLTDP1KDM4EMAPTRAD52
Oxidopamine SCHEMBL28155282 0.97 RECQL (1.00) RECQLTDP1KDM4EMAPTRAD52
Oxidopamine SCHEMBL37507 0.97 RECQL (1.00) RECQLTDP1KDM4EMAPTRAD52
Oxidopamine SCHEMBL29367988 0.97 RECQL (1.00) RECQLTDP1KDM4EMAPTRAD52
Oxidopamine SCHEMBL29419900 0.95 RECQL (0.95) RECQLTDP1KDM4EMAPTRAD52
Oxidopamine SCHEMBL738049 0.95 RECQL (0.95) RECQLTDP1KDM4EMAPTRAD52
Oxidopamine SCHEMBL20398182 0.93 RECQL (0.91) RECQLTDP1KDM4EMAPTRAD52
Oxidopamine SCHEMBL28036288 0.85 RECQL (0.76) RECQLTDP1KDM4EMAPTRAD52
SCHEMBL12557128 0.83 RECQL (0.74) RECQLTDP1KDM4EMAPTRAD52
SCHEMBL1110886 0.83 RECQL (0.74) RECQLTDP1KDM4EMAPTRAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 216 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119874340-A High-viscosity plastic material and application thereof 无锡市宜刚耐火材料有限公司 2025-04-25 CN claimed
CN-119756437-A Flexible fabric-based touch sensor and preparation method and application thereof 中科纳芯传感科技(滨海)有限责任公司 2025-04-04 CN claimed
CN-119529667-A Mussel-bonded organic silicon marine antifouling paint 常熟理工学院 2025-02-28 CN claimed
CN-117820705-B Organic silicon heat conduction gasket and preparation method thereof 深圳市锦联科技有限公司 2024-11-12 CN claimed
CN-118750649-A Poly-dopamine modified artificial ligament and preparation method thereof 复旦大学 2024-10-11 CN claimed
CN-118727438-A Modified fiber and preparation method thereof 深圳先进电子材料国际创新研究院 2024-10-01 CN claimed
CN-117567747-B Surfactant for underfill, and preparation method and application thereof 深圳先进电子材料国际创新研究院 2024-04-09 CN claimed
CN-117567746-B Aminosilane coupling agent and application thereof in moisture-heat resistant underfill 深圳先进电子材料国际创新研究院 2024-04-09 CN claimed
CN-117551273-B Functional auxiliary agent for underfill, preparation method and application thereof 深圳先进电子材料国际创新研究院 2024-04-05 CN claimed
CN-117820705-A Organic silicon heat conduction gasket and preparation method thereof 深圳市锦联科技有限公司 2024-04-05 CN claimed
US-20100029654-A1 CARDIOVASCULAR COMPOSITIONS AND USE OF THE SAME FOR THE TREATMENT OF ALZHEIMER'S DISEASE MOUNT SINAI SCHOOL OF MEDICINE 2010-02-04 US claimed
WO-2010008486-A2 PLURIPOTENT CELL LINES AND METHODS OF USE THEREOF PARKINSONS INSTITUTE (US) 2010-01-21 WO claimed
EP-2007385-A2 CARDIOVASCULAR COMPOSITION AND USE THE SAME FOR THE TREATMENT OF ALZHEIMERS DISEASE Mount Sinai School of Medicine (US) 2008-12-31 EP claimed
US-20080311497-A1 HOLE BLOCKING LAYER CONTAINING PHOTOCONDUCTORS XEROX CORPORATION (US) 2008-12-18 US claimed
US-20080286670-A1 Photoconductors containing charge transport chelating components XEROX CORPORATION 2008-11-20 US claimed
WO-2007112288-A2 CARDIOVASCULAR COMPOSITION AND USE THE SAME FOR THE TREATMENT OF ALZHEIMERS DISEASE MOUNT SINAI SCHOOL OF MEDICINE (US) 2007-10-04 WO claimed
EP-1611238-A4 GLUTAMATE TRANSPORT MODULATORY COMPOUNDS AND METHODS UNIV JOHNS HOPKINS (US) 2007-07-04 EP claimed
US-20060121488-A1 Glutamate transport modulatory compounds and methods NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2006-06-08 US claimed
EP-1611238-A2 GLUTAMATE TRANSPORT MODULATORY COMPOUNDS AND METHODS Johns Hopkins University (US) 2006-01-04 EP claimed
WO-2004076675-A2 GLUTAMATE TRANSPORT MODULATORY COMPOUNDS AND METHODS JOHNS HOPKINS UNIVERSITY (US) 2004-09-10 WO claimed